Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Barry

Showing results (361-370 of 420) with videos related to

Pageof 42
Sort By:
The Journal of Antimicrobial Chemotherapy|November 1, 1982
Ceftizoxime: collaborative multiphased in-vitro evaluation including tentative interpretive standards for disc susceptibility tests, beta-lactamase stability, and inhibitionA L Barry, R N Jones, C Thornsberry, et al.
Journal of Clinical Microbiology|January 1, 1989
Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory StandardsA L Barry, P C Fuchs, S D Allen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactamM A Pfaller, A L Barry, P C Fuchs, et al.
Journal of Clinical Microbiology|June 1, 1982
Accuracy and precision of the autobac system for rapid identification of Gram-negative bacilli: a collaborative evaluationA L Barry, T L Gavan, P B Smith, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1986
In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolatesP C Fuchs, R N Jones, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1984
In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centersA L Barry, R N Jones, L W Ayers, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1996
In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limitsA L Barry, P C Fuchs, S D Allen, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1995
Tests for susceptibility of Streptococcus pneumoniae to cefdinir: proposed interpretive criteria and quality control parameters for both microdilution and disc diffusion methodsP C Fuchs, A L Barry, F C Tenover, et al.
Clinical Therapeutics|January 1, 1980
Antimicrobial activity and spectrum of cefoperazone against recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1993
In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of EnterobacteriaceaeP C Fuchs, A L Barry, M A Pfaller, et al.
Pageof 42

Showing results (361-370 of 420) with videos related to

Sort By:
Pageof 42
The Journal of Antimicrobial Chemotherapy|November 1, 1982
Ceftizoxime: collaborative multiphased in-vitro evaluation including tentative interpretive standards for disc susceptibility tests, beta-lactamase stability, and inhibitionA L Barry, R N Jones, C Thornsberry, et al.
Journal of Clinical Microbiology|January 1, 1989
Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory StandardsA L Barry, P C Fuchs, S D Allen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactamM A Pfaller, A L Barry, P C Fuchs, et al.
Journal of Clinical Microbiology|June 1, 1982
Accuracy and precision of the autobac system for rapid identification of Gram-negative bacilli: a collaborative evaluationA L Barry, T L Gavan, P B Smith, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1986
In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolatesP C Fuchs, R N Jones, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1984
In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centersA L Barry, R N Jones, L W Ayers, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1996
In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limitsA L Barry, P C Fuchs, S D Allen, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1995
Tests for susceptibility of Streptococcus pneumoniae to cefdinir: proposed interpretive criteria and quality control parameters for both microdilution and disc diffusion methodsP C Fuchs, A L Barry, F C Tenover, et al.
Clinical Therapeutics|January 1, 1980
Antimicrobial activity and spectrum of cefoperazone against recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1993
In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of EnterobacteriaceaeP C Fuchs, A L Barry, M A Pfaller, et al.
Pageof 42